Dr. Jonathan Strober, M.D

NPI: 1457454308
Total Payments
$236,818
2024 Payments
$9,370
Companies
14
Transactions
248

Payment Breakdown by Category

Other$147,971 (62.5%)
Consulting$57,449 (24.3%)
Travel$25,523 (10.8%)
Food & Beverage$5,824 (2.5%)
Education$51.80 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $139,334 40 58.8%
Consulting Fee $57,449 19 24.3%
Travel and Lodging $25,523 81 10.8%
Honoraria $8,637 6 3.6%
Food and Beverage $5,824 100 2.5%
Education $51.80 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $186,120 172 $0 (2024)
Sarepta Therapeutics, Inc. $22,351 30 $0 (2024)
Novartis Gene Therapies, Inc. (fka AveXis, Inc.) $7,192 5 $0 (2022)
PFIZER INC. $6,000 3 $0 (2024)
PTC Therapeutics, Inc. $3,646 12 $0 (2018)
Alexion Pharmaceuticals, Inc. $3,083 3 $0 (2022)
APO-PHARMA INC. $3,017 3 $0 (2017)
Janssen Global Services, LLC $2,277 9 $0 (2024)
NS Pharma, Inc. $1,327 2 $0 (2022)
ARGENX US, INC. $1,309 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $9,370 18 Biogen, Inc. ($3,678)
2023 $22,223 25 Biogen, Inc. ($19,050)
2022 $27,427 34 Biogen, Inc. ($12,636)
2021 $10,587 13 Biogen, Inc. ($7,579)
2020 $17,439 9 Sarepta Therapeutics, Inc. ($6,860)
2019 $24,803 25 Biogen, Inc. ($24,540)
2018 $93,508 82 Biogen, Inc. ($89,706)
2017 $31,461 42 Biogen, Inc. ($23,860)

All Payment Transactions

248 individual payment records from CMS Open Payments — Page 1 of 10

Date Company Product Nature Form Amount Type
12/03/2024 Biogen, Inc. SKYCLARYS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,042.00 General
Category: Neurology
11/12/2024 Biogen, Inc. SPINRAZA (Biological), SKYCLARYS Food and Beverage In-kind items and services $32.89 General
Category: Neurology
10/15/2024 Janssen Global Services, LLC Travel and Lodging In-kind items and services $1,075.00 General
10/15/2024 Janssen Global Services, LLC Travel and Lodging In-kind items and services $650.31 General
10/15/2024 Janssen Global Services, LLC Travel and Lodging In-kind items and services $297.90 General
10/15/2024 Janssen Global Services, LLC Travel and Lodging Cash or cash equivalent $49.16 General
10/15/2024 Janssen Global Services, LLC Food and Beverage In-kind items and services $25.37 General
10/15/2024 Janssen Global Services, LLC Travel and Lodging Cash or cash equivalent $13.64 General
10/14/2024 Janssen Global Services, LLC Food and Beverage Cash or cash equivalent $65.00 General
10/14/2024 Janssen Global Services, LLC Travel and Lodging Cash or cash equivalent $52.02 General
10/14/2024 Janssen Global Services, LLC Travel and Lodging Cash or cash equivalent $49.03 General
08/14/2024 Sarepta Therapeutics, Inc. Food and Beverage In-kind items and services $114.37 General
08/08/2024 PFIZER INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
08/08/2024 ITF Therapeutics LLC Food and Beverage In-kind items and services $300.00 General
06/11/2024 Biogen, Inc. SPINRAZA (Biological) Food and Beverage In-kind items and services $131.59 General
Category: Neurology
04/25/2024 Biogen, Inc. SKYCLARYS (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,563.00 General
Category: Neurology
02/29/2024 Biogen, Inc. QALSODY (Drug), SPINRAZA, SKYCLARYS Food and Beverage In-kind items and services $127.01 General
Category: Neurology
02/15/2024 Biogen, Inc. SKYCLARYS (Drug) Consulting Fee Cash or cash equivalent $782.00 General
Category: Neurology
12/07/2023 Sarepta Therapeutics, Inc. Food and Beverage In-kind items and services $34.54 General
12/06/2023 Biogen, Inc. SPINRAZA (Biological) Food and Beverage In-kind items and services $6.18 General
Category: Neurology
12/01/2023 Biogen, Inc. Spinraza (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $5,928.00 General
Category: Neurology
12/01/2023 Biogen, Inc. Spinraza (Biological) Travel and Lodging In-kind items and services $433.00 General
Category: Neurology
12/01/2023 Biogen, Inc. Spinraza (Biological) Travel and Lodging Cash or cash equivalent $213.00 General
Category: Neurology
12/01/2023 Biogen, Inc. Spinraza (Biological) Travel and Lodging In-kind items and services $190.00 General
Category: Neurology
12/01/2023 Biogen, Inc. Spinraza (Biological) Food and Beverage In-kind items and services $73.75 General
Category: Neurology

About Dr. Jonathan Strober, M.D

Dr. Jonathan Strober, M.D is a Pediatrics healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457454308.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Strober, M.D has received a total of $236,818 in payments from pharmaceutical and medical device companies, with $9,370 received in 2024. These payments were reported across 248 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($139,334).

Practice Information

  • Specialty Pediatrics
  • Other Specialties Neurology with Special Qualifications in Child Neurology
  • Location San Francisco, CA
  • Active Since 09/06/2006
  • Last Updated 09/11/2025
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1457454308

Products in Payments

  • SPINRAZA (Biological) $147,285
  • Spinraza (Biological) $18,682
  • TECFIDERA (Drug) $7,970
  • ZOLGENSMA (Biological) $7,291
  • EXONDYS 51 (Drug) $4,643
  • Emflaza (Drug) $3,562
  • SKYCLARYS (Drug) $3,387
  • Soliris (Drug) $2,955
  • DEFERIPRONE (Drug) $2,515
  • VILTEPSO (Drug) $1,327
  • VYVGART (Drug) $1,309
  • FERRIPROX 500 MG/1 TABLET (Drug) $501.64
  • Exondys 51 (Drug) $191.04
  • ULTOMIRIS (Biological) $128.23
  • QALSODY (Drug) $127.01
  • POMPE - DISEASE (Drug) $81.84
  • Dysport 300 U-1 (Drug) $14.49

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in San Francisco